Tirzepatide is a weight loss drug for adults with obesity or with overweight who also have weight-related medical problems, as Zepbound in the US and Mounjaro in some countries outside of the US ...

In a nutshell Tirzepatide (Mounjaro) produced 20.2% weight loss compared to semaglutide’s (Wegovy) 13.7% after 72 weeks of ...

KATHRYN Thomas has opened up about her “amazing” new job and told fans to “watch this space” for what’s coming next. The radio star joined Six O’Clock Show ...

Weight loss drugs and jabs have become more popular and a recent study looked at the effectiveness of two drugs ...

Zaina Jasser urges patients and medical practitioners to be cautious of the moral and sociological implications of ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Trump shared the anecdote as he signed an order Monday intended to drastically reduce the price Americans pay for pharmaceutical products — without naming the friend he was talking about.

President Donald Trump signed an executive order on Monday aimed at slashing prescription drug prices in the U.S. that could ...

The effects they have on your body and mind vary, as Wegovy flips one appetite switch in your brain, while Mounjaro flips two ...

Both the Mounjaro and Wegovy jabs used in the trial were found to be effective treatments for patients with obesity, but one ...

Eventually, it was proven that Mounjaro is more affective than Wegovy in terms of weight loss, with 32 per cent of ...